Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2016 / Jan / Drugs From the Deep
Research & Innovations

Drugs From the Deep

Marine mammals have tear films filled with interesting antimicrobial agents – and understanding the compounds present might one day lead to new antibiotic drugs

By Michael Schubert 1/15/2016 1 min read

Share

Figure 1. E. coli growth (as measured by turbidity assay, OD600) during incubation with three samples of manatee tears (MT), three samples of dolphin tears (DT), and one sample of pooled human tears (HT), as well as with the antibiotic gentamicin as a positive control.

The human eye is an impressive construct, designed to constantly protect and lubricate itself by secreting tears. But there are some animals whose eyes have to protect themselves against far more difficult conditions: marine mammals, who spend most of all of their time in the harsh ocean water. The seas have hosted marine mammals for nearly 50 million years (1) – and in that time, appears that those mammals have evolved unique mechanisms to cope with their environment: an impressively antimicrobial tear film. Recently, researchers from Schepens Eye Institute and Massachusetts Eye and Ear (Boston) examined the tear film and saliva of bottlenose dolphins, rough-toothed dolphins and manatees to see whether those substances have antimicrobial activity (2).

Figure 2. E. coli growth (as measured by turbidity assay, OD600) during incubation with samples of pooled bottlenose dolphin, rough-toothed dolphin, and human tears (and the antibiotic gentamicin as a positive control).

To check for antimicrobial effects, dolphin, manatee and human tear samples were incubated with strains of Escherichia coli and Pseudomonas aeruginosa. The researchers found that in as little as two hours, all three tear types showed significant inhibition of E. coli growth (see Figures 1 and 2). Though the tears had little effect on the slower-growing P. aeruginosa, other tests using dolphin saliva showed that it was able to inhibit growth of the bacterium at 4, 4.5 and 22.5 hours of incubation. The results of the early study indicate an antimicrobial effect of marine mammal tears, but there’s a lot more work to do. Next, the scientists have to analyze the composition of the secretions and ascertain which factors are responsible for this activity so that they can be isolated and studied further. A new kind of antibiotic may be hidden beneath the surface of the ocean – but if so, this is only the beginning of the dive into its secrets.

References

  1. MD Uhen, “Evolution of marine mammals: back to the sea after 300 million years”, Anat Rec (Hoboken), 290, 514–522 (2007). PMID: 17516441. R Kelleher Davis, P Argüeso, “Antimicrobial activity detected in ocular and salivary secretions from marine mammals”. IOVS, 56, ARVO E-Abstract 4163 (2015).

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

More Articles by Michael Schubert

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: